Amalia Dolga receives funding from Michael J. Fox Foundation
Parkinson’s disease (PD) is an incurable disease and the second most common neurodegenerative disease, affecting millions of people globally. Degeneration of the neuronal network leads to miscommunication between dopaminergic cells located in various brain regions involved in motor coordination. The transport of mitochondria from one cell to another is critical for maintaining cell function and survival. Transferring healthy mitochondria to another cell in which mitochondrial function is impaired may be a way to reverse the effects of neurodegeneration. Prof. Amalia Dolga of the Groningen Research Institute of Pharmacy (GRIP) received $500,000 funding from the Michael J. Fox Foundation to study these aspects in Parkinson’s disease. These studies will serve as a starting point for the development of new therapies that target mitochondrial dysfunction.
Last modified: | 15 June 2023 4.23 p.m. |
More news
-
17 July 2024
Veni-grants for ten researchers in Groningen
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
15 July 2024
Funding for RUG researchers from National Growth Fund programme Circular Plastics NL
For research on making plastics circular, Professors Patrizio Raffa and Katja Loos together receive about 1.2 million euros from the National Growth Fund programme Circular Plastics NL.
-
09 July 2024
NWO Open Technology funding for improving quality 3D printing technology
Dr. Liangliang Cheng receives a NWO OPT grant of EUR 950,000 for research on safer application of metals in 3D printing technology.